Who Owns DRMAW?
Dermata Therapeutics, Inc. Warrant — Institutional Ownership & 13F Holdings
$0.01
+0.00 (+2.38%)
Market Cap
$12K
Shares Outstanding
681,557
Institutional Holders
3
Total Inst. Value
$13K
% of Float Held
—
QoQ Holder Change
-3
Institutional data as of Q1 2025
New Positions
0
Closed Positions
3
Increased
1
Decreased
1
Institutional Ownership Trend
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | BOOTHBAY FUND MANAGEMENT, LLC | $13K | 12,000 |
| 2 | TWO SIGMA SECURITIES, LLC | $231 | 13,215 |
| 3 | UBS Group AG | $44 | 2,617 |
Biggest Buyers & Sellers This Quarter
Top Buyers
| Fund | Shares Added | Value |
|---|---|---|
| TWO SIGMA SECURITIES, LLC | +358 | $231 |
Top Sellers
| Fund | Shares Removed | Value |
|---|---|---|
| UBS Group AG | -2K | $44 |
Related Stocks
Frequently Asked Questions
How many institutional investors hold DRMAW?
As of Q1 2025, 3 institutional investors report holding DRMAW (Dermata Therapeutics, Inc. Warrant) in their 13F filings.
Which hedge fund owns the most DRMAW?
The largest institutional holder of DRMAW is BOOTHBAY FUND MANAGEMENT, LLC with $13K in shares.
Are institutions buying or selling DRMAW?
This quarter, 0 institutions opened new positions in DRMAW and 3 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.